Quotations about HydroCurc® Pharmacokinetic study

0
783

“Pharmako Biotechnologies are very pleased with the publication of the pharmacokinetic study conducted by the University of Queensland on HydroCurc®. It validates our claim that HydroCurc® is ‘the world’s most bioavailable curcumin in a single dose’.”

Eric Meppem

Co-founder: Pharmako Biotechnologies

“The European Journal of Nutrition is a very respected journal, with an impact factor of 4.423. We are really pleased with not only the interest about the LipiSperse® technology, but also with the commercial interest in HydroCurc® from all around the world.”

Eric Meppem

Co-founder: Pharmako Biotechnologies

“LipiSperse® is a unique technology, developed in the Pharmako Biotechnologies laboratory in Sydney. The enhanced absorption of lipophilic actives as reported in the study conducted at the University of Queensland equals or exceeds any of the other published studies on bioavailable curcumin. The other amazing feature of HydroCurc® is that the LipiSperse® technology delivers 90% active (only 10% excipient).”

George Kokkinis

Co-founder, Technical Director

Pharmako Biotechnologies Pty Ltd

“LipiSperse® is a novel delivery system, unlike other technologies currently used in dietary supplements or foods. As a dispersion technology, it has an advantage over SMEDDS technologies, delivering 90% active. We are very proud to have developed such a unique technology in our laboratory in Sydney.”

Dr Vaskor Bala

Formulation Scientist

Pharmako Biotechnologies Pty Ltd

“HydroCurc® is already being used in many products around the world, due to the functional benefits of the LipiSperse® technology. These include Cold-Water-Dispersion (CWD) and high load of active delivered by LipiSperse® – 90%. The study published in July in the European Journal of Nutrition demonstrates the high bioavailability of HydroCurc®.”

George Kokkinis

Co-founder, Technical Director

Pharmako Biotechnologies Pty Ltd

“The study on LipiSperse® recently published in the European Journal of Nutrition highlights the benefits of our technology combined with curcumin. As well as HydroCurc®, Pharmako Biotechnologies have also developed LipiSperse® formulations for other lipophilic materials.

These include resveratrol, quercetin, silymarin, coenzyme-Q10 and others. Pharmako specialise in optimizing lipophilic formulations for customers around the world.”

Eric Meppem

Co-founder: Pharmako Biotechnologies